A drug that slows disability and reduces relapse rates in multiple sclerosis (MS) has been found to also reduce vision loss in patients with relapsing MS. Vision loss is one of the most common and debilitating symptoms of MS.
Fred R. Volkmar, M.D., director of the Yale Child Study Center and a renowned expert in autism and related disorders, will discuss the expansion of the Center?s specialty clinical services to Greenwich hospital on Monday, April 23, 7 p.m. at Greenwich Library, 101 W. Putnam Ave., Greenwich.
After writing two books on the topic of artists and eye disease, the Stanford University School of Medicine ophthalmologist decided to go one step further and create images that would show how artists with eye disease actually saw their world and their canvases.
Drug-resistant bacteria can complicate treatment after many surgical procedures. In particular, Methicillin-resistant Staphylococcus aureus (MRSA), which has been found in many healthcare settings, can be a serious post-operative complication.
One donor cornea may be divided and transplanted into multiple patients with eye disease or damage, according to a report in the April issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
The number of people in the U.S. with macular degeneration is greater than that with all types of cancer combined. Macular degeneration can lead to blindness, something that people fear even more than premature death. This award will help further research into this condition.
An international team of researchers has come up with a feasible way of making universal red blood cells from any blood type. It is hoped that it might relieve blood bank shortages.
Computers can usually out-compute the human brain, but there are some tasks, such as visual object recognition, that the brain performs easily yet are very challenging for computers.
The European Medicines Agency (EMEA) has recommended restrictions on the use of Ketek (telithromycin) in three of its four approved indications.
For the millions of Americans whose vision is slowly ebbing due to degenerative diseases of the eye, the lowly neural progenitor cell may be riding to the rescue.